Screener
Nurix Therapeutics, Inc. NRIX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026. Open the filing →
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
FAQ
- What is Nurix Therapeutics, Inc.'s invested capital?
- Nurix Therapeutics, Inc. (NRIX) reported invested capital of $392.12M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s invested capital changed year-over-year?
- Nurix Therapeutics, Inc.'s invested capital decreased by 5.4% year-over-year, from $414.37M to $392.12M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s invested capital has grown at a 13.4% compound annual growth rate (CAGR), from $185.16M to $346.55M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Nurix Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude